Pemetrexed User Reviews & Ratings
Brand names: Alimta, Axtle, Pemfexy, Pemrydi RTU
Pemetrexed has an average rating of 9.0 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Non Small Cell Lung Cancer | 2 reviews for Non Small Cell Lung Cancer | 64 medications |
- Mde...
- Taken for 2 to 5 years
- December 21, 2016
For Non Small Cell Lung Cancer "Just finished my 30th cycle today, and overall my side effects have been very tolerable. I have stage 4 bladder cancer and was originally given 3 months of life expectancy. This diagnosis was from the Mayo Clinic. After initial treatments of radiation and 7 or 8 cycles of carboplatin and Gemzar (not sure of chemo spelling). I have been on Alimta ever since with little to no further cancer growth. Overall 2 years and 4 months since treatment began. To say I'm happy is an understatement!!!"
Are you taking this medicine?
Your review helps others make informed decisions.More about pemetrexed
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
- PEMEtrexed monograph
- Pemetrexed (FDA)
- Pemetrexed Injection (FDA)
- Pemetrexed injection, Concentrate (FDA)
Other brands
Alimta, Axtle, Pemfexy, Pemrydi RTU
Pemetrexed for Non Small Cell Lung Cancer "My 81 y/o mother received 6 infusions of Alimta for non-small cell lung cancer. Her cancer has now shrunk. No new cancers. The most severe side effect she suffered was fatigue and water retention. But that was managed by a change in her diuretic medications."